Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study

The aim of the study is to assess the effects of celecoxib and sulfasalazine on the risk of coronary artery disease (CAD) in patients with ankylosing spondylitis (AS). Using the claims data of Taiwan National Health Insurance (NHI) database, a nationally representative data that contain the medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Li-Chih, Leong, Pui-Ying, Yeo, Kai-Jieh, Li, Ting-Yu, Wang, Yu-Hsun, Chiou, Jeng-Yuan, Wei, James Cheng-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023908/
https://www.ncbi.nlm.nih.gov/pubmed/27603385
http://dx.doi.org/10.1097/MD.0000000000004792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023908/
https://www.ncbi.nlm.nih.gov/pubmed/27603385
http://dx.doi.org/10.1097/MD.0000000000004792

Ejemplares similares